Silvercrest Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,372,497
| Closed | -$9.73M | – | 872 |
|
|
2022
Q1 | $9.73M | Buy |
2,372,497
+21,866
| +0.9% | +$79.3K | 0.06% | 260 |
|
|
2021
Q4 | $8.39M | Buy |
2,350,631
+311,564
| +15% | +$1.09M | 0.05% | 292 |
|
|
2021
Q3 | $7.42M | Sell |
2,039,067
-46,969
| -2% | -$190K | 0.05% | 313 |
|
|
2021
Q2 | $9.1M | Buy |
2,086,036
+252,674
| +14% | +$1.03M | 0.06% | 292 |
|
|
2021
Q1 | $7.54M | Sell |
1,833,362
-244,058
| -12% | -$1.06M | 0.05% | 302 |
|
|
2020
Q4 | $8.29M | Sell |
2,077,420
-354,357
| -15% | -$1.15M | 0.06% | 273 |
|
|
2020
Q3 | $6.57M | Buy |
2,431,777
+452,154
| +23% | +$1.25M | 0.06% | 286 |
|
|
2020
Q2 | $5.44M | Buy |
1,979,623
+350,857
| +22% | +$979K | 0.05% | 297 |
|
|
2020
Q1 | $3.84M | Sell |
1,628,766
-5,963
| -0.4% | -$20.3K | 0.04% | 324 |
|
|
2019
Q4 | $7.68M | Sell |
1,634,729
-390,077
| -19% | -$1.6M | 0.06% | 265 |
|
|
2019
Q3 | $6.77M | Buy |
+2,024,806
| New | +$6.67M | 0.06% | 271 |
|